As of 2025-10-17, the EV/EBITDA ratio of Profound Medical Corp (PRN.TO) is -4.80. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRN.TO's latest enterprise value is 198.41 mil CAD. PRN.TO's TTM EBITDA according to its financial statements is -41.34 mil CAD. Dividing these 2 quantities gives us the above PRN.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.5x - 19.3x | 14.9x |
| Forward P/E multiples | 21.2x - 21.9x | 21.6x |
| Fair Price | (39.38) - (35.65) | (33.62) |
| Upside | -592.2% - -545.6% | -520.3% |
| Date | EV/EBITDA |
| 2025-10-15 | -5.09 |
| 2025-10-14 | -5.15 |
| 2025-10-10 | -5.09 |
| 2025-10-09 | -5.86 |
| 2025-10-08 | -6.00 |
| 2025-10-07 | -5.67 |
| 2025-10-06 | -5.05 |
| 2025-10-03 | -5.01 |
| 2025-10-02 | -4.70 |
| 2025-10-01 | -4.20 |
| 2025-09-30 | -4.22 |
| 2025-09-29 | -4.43 |
| 2025-09-26 | -4.60 |
| 2025-09-25 | -4.51 |
| 2025-09-24 | -4.71 |
| 2025-09-23 | -4.36 |
| 2025-09-22 | -3.60 |
| 2025-09-19 | -3.61 |
| 2025-09-18 | -3.42 |
| 2025-09-17 | -3.21 |
| 2025-09-16 | -3.29 |
| 2025-09-15 | -3.38 |
| 2025-09-12 | -3.31 |
| 2025-09-11 | -3.27 |
| 2025-09-10 | -3.16 |
| 2025-09-09 | -3.39 |
| 2025-09-08 | -3.37 |
| 2025-09-05 | -3.45 |
| 2025-09-04 | -3.66 |
| 2025-09-03 | -3.69 |
| 2025-09-02 | -3.77 |
| 2025-08-29 | -3.75 |
| 2025-08-28 | -3.78 |
| 2025-08-27 | -3.80 |
| 2025-08-26 | -3.80 |
| 2025-08-25 | -4.02 |
| 2025-08-22 | -4.06 |
| 2025-08-21 | -4.03 |
| 2025-08-20 | -3.92 |
| 2025-08-19 | -3.91 |
| 2025-08-18 | -4.08 |
| 2025-08-15 | -3.61 |
| 2025-08-14 | -4.76 |
| 2025-08-13 | -4.78 |
| 2025-08-12 | -4.89 |
| 2025-08-11 | -4.88 |
| 2025-08-08 | -4.90 |
| 2025-08-07 | -4.91 |
| 2025-08-06 | -4.87 |
| 2025-08-05 | -4.82 |